Commence Bio (formerly Wibi+Works) is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells. Commence aims to apply these methods in various inflammation-related disorders, including rheumatoid arthritis, by creating uniform cellular therapeutics with predictable behaviors.
www.commencebio.com
www.commencebio.com
Investors 1
| Date | Name | Website |
| - | New Orlean... | neworleans... |
Mentions in press and media 1
| Date | Title | Description |
| - | FG set to commence disbursement from $350 million Cabotage Vessel Financing Fund | - |